Literature DB >> 9071436

HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant.

D J Choi1, S Dube, T P Spicer, H B Slade, F C Jensen, B J Poiesz.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9071436     DOI： 10.1089/aid.1997.13.357

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  9 in total

1.  Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination.

Authors:  R B Moss; M R Wallace; R T Steigbigel; S A Morrison; W K Giermakowska; C J Nardo; J P Diveley; D J Carlo
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Human immunodeficiency virus type 1 intersubtype (B/E) recombination in a superinfected chimpanzee.

Authors:  P N Fultz; L Yue; Q Wei; M Girard
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.

Authors:  Janina Q Jiang; Amy Patrick; Ronald B Moss; Kenneth L Rosenthal
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected thai subjects with CD4-cell counts of >300.

Authors:  V Churdboonchart; C Sakondhavat; S Kulpradist; B I Na Ayudthya; V Chandeying; S Rugpao; C Boonshuyar; W Sukeepaisarncharoen; W Sirawaraporn; D J Carlo; R Moss
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

5.  T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune).

Authors:  R B Moss; W Giermakowska; M R Wallace; J Savary; F Jensen; D J Carlo
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

6.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen.

Authors:  R B Moss; W K Giermakowska; M R Wallace; F C Jensen; R Z Maigetter; D J Carlo
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

8.  An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I).

Authors:  F Gao; D L Robertson; C D Carruthers; Y Li; E Bailes; L G Kostrikis; M O Salminen; F Bibollet-Ruche; M Peeters; D D Ho; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model.

Authors:  Ronald B Moss; Jay R Savary; Jocelyn P Diveley; Fred Jensen; Dennis J Carlo
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.